Altimmune (ALT) EBITDA Margin Growth (3y) (2013 - 2025)
Altimmune (ALT) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.23 Mn |
| Sep 30, 2025 | 82.04 Mn |
| Jun 30, 2025 | -20.35 Mn |
| Mar 31, 2025 | -37.54 Mn |
| Dec 31, 2024 | -49.66 Mn |
| Sep 30, 2024 | -47.43 Mn |
| Jun 30, 2024 | -51.68 Mn |
| Mar 31, 2024 | -53.41 Mn |
| Dec 31, 2023 | -9.04 Mn |
| Sep 30, 2023 | -560,282.00 |
| Jun 30, 2023 | -29.97 Mn |
| Mar 31, 2023 | -10.33 Mn |
| Dec 31, 2022 | -8.81 Mn |
| Sep 30, 2022 | -123.58 Mn |
| Jun 30, 2022 | -25.47 Mn |
| Mar 31, 2022 | -6.09 Mn |
| Dec 31, 2021 | 32,446.00 |
| Sep 30, 2021 | -2.09 Mn |
| Jun 30, 2021 | -1.79 Mn |
| Mar 31, 2021 | -155,062.00 |